Cargando…
Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study
INTRODUCTION: To assess the efficacy and safety of the interleukin-1 receptor (IL-1R) inhibitor anakinra in adult patients with refractory Still's disease. METHODS: Twenty-five patients (13 males and 12 females, median age 32 years, median disease duration seven months) with Still's diseas...
Autores principales: | Laskari, Katerina, Tzioufas, Athanasios G, Moutsopoulos, Haralampos M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218906/ https://www.ncbi.nlm.nih.gov/pubmed/21682863 http://dx.doi.org/10.1186/ar3366 |
Ejemplares similares
-
Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study
por: Laskari, Katerina, et al.
Publicado: (2010) -
Anakinra in children and adults with Still’s disease
por: Vastert, Sebastiaan J, et al.
Publicado: (2019) -
Clinical and Laboratory Predictors of Distinct Histopathogical Features of Lupus Nephritis
por: Mavragani, Clio P., et al.
Publicado: (2015) -
Anakinra in Still’s disease: a profile of its use
por: Lyseng-Williamson, Katherine A.
Publicado: (2018) -
Long-Term Retention Rate of Anakinra in Adult Onset Still’s Disease and Predictive Factors for Treatment Response
por: Vitale, Antonio, et al.
Publicado: (2019)